Xi Jiang, PhD^1,2, Jason Bugno^3*, Chao Hu^1,2,4*, Yang Yang, PhD^3*, Tobias Herold, MD^5*, Jun Qi, PhD^6*, Ping Chen², Sandeep Gurbuxani, MBBS, PhD⁷, Stephen Arnovitz^2*, Bryan Ulrich^2*, Hengyou Weng, PhD^1,2*, Yungui Wang, PhD^1,2,4*, Hao Huang, PhD², Shenglai Li^2*, Jennifer Strong^1*, Mary Beth Neilly^2*, Richard A. Larson, MD⁸, Michelle M. Le Beau, PhD², Stefan K. Bohlander, MD^9*, Jie Jin, MD, PhD¹⁰, Zejuan Li, MD, PhD², James E. Bradner, MD¹¹, Seungpyo Hong, PhD^3,12* and Jianjun Chen, PhD^1,2

¹Department of Cancer Biology, University of Cincinnati, Cincinnati, OH
²Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
³Department of Biopharmaceutical Sciences College of Pharmacy, The University of Illinois, Chicago, IL
⁴Department of Hematology, The First Affiliated Hospital Zhejiang University, Hangzhou, China
⁵Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-Universität, Munich, Germany
⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁷Department of Pathology, University of Chicago, Chicago, IL
⁸University of Chicago Medical Center, Chicago, IL
⁹Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand
¹⁰Key Laboratory of Hematopoietic Malignancies, Zhejiang Province, Hangzhou, China
¹¹Harvard Medical School, Boston, MA
¹²Division of Integrated Science & Engineering, Underwood International College, Yonsei University, Incheon, South Korea

May S.K. Sutherland, PhD^1*, Changpu Yu^1*, Christine O'Day, PhD^1*, Steve Alley, PhD^1*, Martha Anderson^1*, Kim Emmerton^1*, Weipeng Zeng^1*, Megan M. O'Meara, MD², Eric J. Feldman, MD², Dana A. Kennedy³, Maureen C. Ryan, PhD^1* and Dennis Benjamin, PhD^1*

¹Translational Research, Seattle Genetics, Inc., Bothell, WA
²Clinical Development, Seattle Genetics, Inc., Bothell, WA
³Seattle Genetics, Inc., Bothell, WA

Ronan T. Swords, MD, PhD, FRCPI, FRCPath¹, Aymee Perez, PhD^2*, Ana Rodriguez^2*, Justin M. Watts, MD^2*, Tino Schenk, PhD^3*, Fernando Vargas, MD^2*, Roy Elias^2* and Arthur Zelent, PhD²

¹Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami Hospitals, Miami, FL
²Sylvester Comprehensive Cancer Center, University of Miami, Miami
³Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom

Mathilde Hunault, MD, PhD^1*, Nathalie Maillard, MD^2*, Aline Tanguy-Schmidt, MD^3*, Chantal Himberlin, MD^4*, Bachra Choufi, MD^5*, Caroline Bonmati, MD^6*, Marie Anne Couturier, MD^7*, Eric Deconinck, MD, PhD⁸, Jean Pierre Marolleau, MD, PhD⁹, Frédérique Orsini-Piocelle, MD^10*, Jacques Delaunay, MD^11*, Emmanuelle Tavernier, MD^12*, Christian Récher, MD PhD¹³, Severine Lissandre, MD^14*, Mario Ojeda-Uribe, MD^15*, Laurence Sanhes, MD^16*, Laurent Sutton, MD^17*, Anne Banos, MD^18*, Bruno Lioure, MD^19*, Marc Bernard, MD^20*, Didier Bouscary, MD PhD^21*, Alain Saad, MD^22*, Valérie Rouille^23*, Philippe Guardiola, MD²⁴, Isabelle Luquet, MD^25*, Marie C Bene, PharmSciD, PhD^26*, Francois Dreyfus, MD^27*, Jean-Yves Cahn, MD²⁸, Arnaud Pigneux^29* and Norbert Ifrah, MD^30,31

¹Hematology Department, CHU, Angers, France
²CHU, Poitiers, France
³University Hospital of Angers, Angers, France
⁴CHU, Reims, France
⁵Hôpital de Boulogne-sur-Mer, Boulogne-sur-Mer, France
⁶CHU Nancy, Nancy, France
⁷CHU, Brest, France
⁸Department of Hematology, CHU Besancon, Besancon, France
⁹Département d'hématologie clinique, Centre hospitalier universitaire Amiens, Amiens, France
¹⁰CH, Annecy, France
¹¹Department of Hematology, Nantes University Hospital, Nantes, France
¹²108 bis avenue Albert Raimond Hematology, Institut de Cancérologie de la Loire, Saint Priez en jarez, 42271, France
¹³Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
¹⁴CHU, Tours, France
¹⁵Hematology and Cellular Therapy Unit, GHRMSA, Hôpital E Muller, Mulhouse, France
¹⁶CHU, Perpignan, France
¹⁷Hematology Department, Argenteuil Hospital, Argenteuil, France
¹⁸Hematology Department, CH Cote basque, Bayonne, France
¹⁹Department of Hematology and Oncology, CHU Hautepierre, Strasbourg, France
²⁰CHU Rennes, Hematology, Rennes, France
²¹CHU Cochin, Paris, France
²²CH, Béziers, France
²³CHU, Montpellier, France
²⁴Hematology, CHU, Angers, France
²⁵CHU Toulouse, Toulouse, France
²⁶Hematology Laboratory, Nantes University Hospital, Nantes, France
²⁷Hopital Cochin, paris, France
²⁸Hematology Department, CHU de Grenoble, Grenoble, France
²⁹Hematology, Hôpital Haut Lêveque, Pessac, France
³⁰PRES LUNAM, CHU Angers service des Maladies du Sang et INSERM U 892, Angers, France
³¹INSERM U892, Université d'Angers, Angers, France

Remco Molenaar, M.Sc.^1*, Bhumika J. Patel^2*, Mohammed Khurshed, M.D.^3*, Bartlomiej Przychodzen, MSc^2*, Srinivasa Reddy Sanikommu, MD⁴, Hetty E. Carraway, MD, MBA⁵, Tomas Radivoyevitch, PhD^6*, Hideki Makishima, MD, Ph.D.^7,8, Cornelis J van Noorden, PhD^9* and Jaroslaw P. Maciejewski, MD, PhD¹⁰

¹Translational Hematology & Oncology Research, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
²Department of Translational Hematology and Oncology Research, Taussing Cancer Institute, Cleveland Clinic, Cleveland, OH
³Cell Biology & Histology, Academic Medical Center, Amsterdam, Netherlands
⁴Departemnt of Translational Hematology and Oncology, Cleveland Clinic Taussing Cancer Institute, Cleveland, OH
⁵Leukemia Program, Cleveland Clinic, Cleveland, OH
⁶Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
⁷Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH
⁸Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
⁹Department of Cell Biology & Histology, Academic Medical Center, Amsterdam, Netherlands
¹⁰Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Walter Fiedler, MD¹, Jörg Chromik^2*, Maxim Kebenko^3*, Felicitas Thol, MD⁴, Arne Trummer, MD^4*, Chirstoph Schünemann^5*, Christian H. Brandts, MD^6*, Anne Köhler^7*, Vera Schlipfenbacher^2*, Carsten Bokemeyer, MD^8*, Susann Theile^9*, Anne L. Kranich^10* and Michael Heuser, MD⁴

¹Department of Hematology and Oncology with sections Pneumonology and Bone Marrow Transplantation, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
²University Hospital Frankfurt, Frankfurt, Germany
³University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁴Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
⁵Hannover Medical School, Hannover, Germany
⁶Hematology/Oncology, Goethe University Frankfurt, Frankfurt, Germany
⁷Dept. of Medicine II, Hematology/Oncology, Goethe University Hospital Frankfurt, Frankfurt/Main, Germany
⁸Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁹GSO Hamburg, Hamburg, Germany
¹⁰GSO Global B.V., Amsterdam, Netherlands

Weiguo Zhang, M.D., Ph.D.¹, Nalini Patel^2*, William E. Fogler, Ph.D.^3*, John L. Magnani, PhD⁴ and Michael Andreeff, MD, PhD⁵

¹Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
²The University of Texas MD Anderson Cancer Center, Houston, TX
³GlycoMimetics, Inc., Rockville, MD
⁴GlycoMimetics, Inc., Gaithersburg, MD
⁵Section of Molecular Hematology and Therapy, Leukemia Department, UT MD Anderson Cancer Center, Houston, TX

Kalpana Gupta, PhD^1*, Gary Parizher, BS^1*, Marcos De Lima, MD² and David N. Wald, MD PhD^3,4*

¹Pathology, Case Western Reserve University, Cleveland, OH
²Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH
³Department of Pathology, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH
⁴Pathology, University Hospitals Case Medical Center, cleveland, OH

Neerav Shukla, MD^1*, Maureen M. O'Brien, MD², Lewis B. Silverman, MD³, Melinda Pauly, MD^4*, Cynthia Wetmore, MD, PhD^5*, Mignon L. Loh, MD⁶, James A. Whitlock, MD⁷, Patrick Brown, MD⁸, Blythe Thomson, MD⁹, Stephen J. Blakemore, PhD^9*, Scott Daigle^9*, Patricia Pimentel^9*, Nigel J. Waters, PhD^9*, Andrei V Krivstov, PhD^10*, Richard Koche, PhD^10*, Scott A. Armstrong, MD, PhD¹¹, Peter T Ho, PhD, MD⁹ and Lia Gore, M.D.¹²

¹Memorial Sloan Kettering, New York
²Cincinnati Children's Hospital Medical Center, Cincinnati, OH
³Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA
⁴Department of Pediatrics, Children’s Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA
⁵Emory University, Atlanta, GA
⁶Department of Pediatrics, Benioff Children’s Hospital, University of California at San Francisco, San Francisco, CA
⁷Hospital for Sick Children, Toronto, ON, Canada
⁸Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD
⁹Epizyme, Inc, Cambridge, MA
¹⁰Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Memorial Sloan-Kettering Cancer Center, New York, NY
¹²Pediatrics, Section of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado Denver, Aurora, CO

Kathrin Rothfelder^1,2*, Samuel Koerner^1,2*, Maya Andre^3,4*, Julia Leibold^5*, Philaretos Kousis^1,2*, Hans-Jörg Bühring^2*, Sebastian P. Haen, MD^6*, Ayline Kuebler^3,4*, Lothar Kanz, MD², Ludger Grosse-Hovest^7*, Gundram Jung^5* and Helmut R Salih, MD^1,6

¹Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tuebingen, Tuebingen, Germany
²Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany
³University Children´s Hospital, Dep. of Pediatric Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany
⁴University Children´s Hospital, Dep. of Pediatric Intensive Care, Basel, Switzerland
⁵Department for Immunology, Eberhard Karls University, Tuebingen, Germany
⁶Department of Hematology and Oncology, University of Tuebingen, Tuebingen, Germany
⁷Synimmune GmbH, Tuebingen, Germany, Tuebingen, Germany

Joseph G. Jurcic, MD¹, Farhad Ravandi, MD², John M. Pagel, MD, PhD^3*, Jae H. Park, MD⁴, B. Douglas Smith, MD⁵, Moshe Yair Levy, MD^6*, Elihu H. Estey, MD⁷, Alexander E. Perl, MD⁸, Hagop Kantarjian, MD⁹, Dennis Earle^10*, Dragan Cicic, MD^10* and David A. Scheinberg, MD, PhD¹¹

¹Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Swedish Medical Center, Seattle, WA
⁴Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
⁶Charles A Sammons Cancer Center, Texas Oncology-Baylor, Dallas, TX
⁷Fred Hutchinson Cancer Research Center / University of Washington, Seattle, WA
⁸Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA
⁹Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Actinium Pharmaceuticals, Inc., New York, NY
¹¹Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY

Kendra L. Sweet, MD¹, Naveen Pemmaraju, MD², Andrew A Lane, MD, PhD³, Anthony S. Stein, MD⁴, Sumithira Vasu, MBBS⁵, William Blum, MD⁶, David A. Rizzieri, MD⁷, Eunice S. Wang, MD⁸, Eric K. Rowinsky, MD^9*, Michael Szarek, PhD^9*, Christopher L. Brooks, PhD⁹, Sarah Disalvatore, MPH^9*, David Liu^9*, Madeleine Duvic, MD¹⁰, Jonathan D. Schwartz, MD⁹ and Marina Konopleva, MD, PhD¹¹

¹Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
⁵Comprehensive Cancer Center, The Ohio State University, Columbus, OH
⁶The Ohio State University, Columbus, OH
⁷Dept. of Medicine, Div. of Hematological Malignancies & Cellular Therapy, Duke University Medical Center, Durham, NC
⁸Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
⁹Stemline Therapeutics, Inc., New York, NY
¹⁰Dept. of Dermatology, M.D. Anderson Cancer Center, Houston, TX
¹¹Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Yoko Ogawara, PhD^1*, Hironori Matsunaga^2*, Takahiko Seki, PhD^2*, Yukino Machida^1*, Kazushi Araki, D.V.M., Ph.D.^2* and Issay Kitabayashi, PhD¹

¹Division of Hematological Malignancy, National Cancer Center Research Institute, Tokyo, Japan
²R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan

Amanda L Christie, B.S.^1*, Yvonne Li, PhD^2*, Katsuhiro Togami, MD^2*, Mahmoud Ghandi, PhD^3*, Alexandra N. Christodoulou, M.S.^1*, Kevin Buczkowski^2*, Fanny Angelot-Delettre, PhD^4*, Sabeha Biichle^4*, Janice Chen, PhD^5*, Christopher L. Brooks, PhD⁵, David M. Weinstock, MD², Francine Garnache-Ottou, PhD^4*, Peter S Hammerman, MD, PhD^2* and Andrew A Lane, MD, PhD¹

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Dana-Farber Cancer Institute, Boston, MA
³Broad Institute, Cambridge, MA
⁴INSERM UMR 1098/Université Bourgogne Franche-Comté/EFS BFC, Besancon, France
⁵Stemline Therapeutics, Inc., New York, NY

Iris Bigalke^1*, Yngvar Fløisand, MD, PhD^2*, Guri Solum^1*, Kirsti Hønnåshagen^1*, Marianne Lundby^1*, Kristina Anderson, MD, PhD^1*, Stein Sæbøe-Larssen, PhD^1*, Else-Marit Inderberg, PhD^1*, Judith Eckl, PhD^3*, Dolores J Schendel, PhD^3* and Gunnar Kvalheim, MD, PhD¹

¹Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway
²Department of Hematology, Oslo University Hospital, Oslo, Norway
³Medigene Immunotherapies GmbH, München, Germany

Wontak Kim^1*, Brigham L. Bahr^1*, Katherine K. Soh^1*, Jeremiah J. Bearss^1*, Ye Sol Lee^2*, Peter Peterson, PhD^1*, Clifford J. Whatcott, PhD^1*, Adam Siddiqui-Jain, PhD^3*, Steven Weitman, MD, PhD^3*, David J. Bearss, PhD³ and Steven L. Warner, PhD³

¹Discovery Biology, Tolero Pharmaceuticals, Inc., Lehi, UT
²Discovery Biology, Tolero Pharmaceuticals, Lehi, UT
³Tolero Pharmaceuticals, Inc., Lehi, UT

Guillermo Garcia-Manero, MD¹, Hui Yang, MD, PhD¹, Zhihong Fang^1*, Courtney DiNardo, MD¹, Elias Jabbour, MD¹, Naveen Pemmaraju, MD¹, Ricardo Delumpa, RN^1*, Christopher Loiselle, RN^1*, Susan Denton, RN^2*, Whitney Smith^2*, Hiroyuki Iwamura, PhD^3*, Teletha Gipson, PhD^4*, Michele Rosner, MS^4*, Timothy Madden, PharmD^4*, Thomas J. Myers, MD⁴ and Linda J. Paradiso, DVM, MBA⁴

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Westat Corporation, Houston, TX
³FUJIFILM Corporation, Tokyo, Japan
⁴Strategia Therapeutics, Inc., Houston, TX

Maro Ohanian, DO^1*, Hagop M. Kantarjian, MD¹, Farhad Ravandi, MD¹, Gautam Borthakur, MD¹, Guillermo Garcia-Manero, MD², Michael Andreeff, MD, PhD³, Elias Jabbour¹, Marina Konopleva, MD, PhD¹, Miranda Lim, BSN^1*, Sherry Pierce, BSN, BA^1*, Susan O'Brien, MD¹, Bradley G. Somer, MD^4*, Ana Tari, PhD^5*, William Wierda, MD, PhD⁶, Srdan Verstovsek, MD¹ and Jorge E. Cortes, MD⁷

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, MD Anderson Cancer Center, Houston, TX
³Section of Molecular Hematology & Therapy, Department of Leukemia; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁴West Clinic, Memphis, TN
⁵4710 Bellaire Blvd, Suite 210, Bio-Path Holdings,inc, Bellaire, TX
⁶University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Nina C. Zitzer, DVM^1*, Parvathi Ranganathan, PhD^2*, Brent A Dickinson, BA^3*, Aimee L Jackson, PhD^3*, David M Rodman, MD^3*, Carlo M. Croce, MD⁴, Guido Marcucci, MD^5* and Ramiro Garzon, MD¹

¹Comprehensive Cancer Center, The Ohio State University, Columbus, OH
²The Comprehensive Cancer Center, The Ohio State University, Columbus, OH
³miRagen Therapeutics, Boulder, CO
⁴The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁵Division of Hematopoietic Stem Cell and Leukemia Research of Beckman Research Institute, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA

Anjali S. Advani, MD¹, Hongli Li, PhD^2*, Laura C. Michaelis, MD³, Bruno C. Medeiros, MD⁴, Michaela Liedtke, MD⁵, Alan F. List, MD⁶, Kristen O'Dwyer, MD^7*, Megan Othus, PhD^2*, Harry P. Erba, MD, PhD^8* and Frederick R Appelbaum, MD⁹

¹Leukemia Program, Cleveland Clinic, Cleveland, OH
²SWOG Statistical Center, Seattle, WA
³Medical College of Wisconsin, Milwaukee, WI
⁴Department of Medicine, Division of Hematology, Stanford University, Stanford, CA
⁵Stanford Cancer Institute, Stanford, CA
⁶Department of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL
⁷James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
⁸University of Alabama at Birmingham and UAB Comprehensive Cancer Center, Birmingham, AL
⁹Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Hagop Kantarjian, MD¹, Elias Jabbour, MD¹, Guillermo Garcia-Manero, MD², Tapan Kadia, MD³, Courtney DiNardo, MD¹, Naval Daver, MD¹, Gautam Borthakur, MD¹, Nitin Jain, MD¹, Jane Waukau, RN, BSN^1*, Monica Kwari, RN, BSN¹, Barry Douglas Anderson, MD, PhD^4*, Kenzo Iizuka^5*, Cheng Jin, MD, PhD^5* and William Plunkett, PhD¹

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Theradex Systems Inc., Princeton, NJ
⁵Delta-Fly Pharma Inc., Tokushima, Japan

Katrin Deiser^1,2*, Felix S. Lichtenegger^1,2*, Frauke Schnorfeil^1,2*, Thomas Koehnke^1*, Torben Altmann^1*, Veit Buecklein^1*, Andreas Moosmann^3*, Monika Brueggemann^4*, Beate Wagner^5*, Wolfgang Hiddemann¹, Iris Bigalke^6*, Gunnar Kvalheim⁶ and Marion S. Subklewe, MD^1,2

¹Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany
²Clinical Cooperation Group Immunotherapy, Helmholtz Zentrum München, Munich, Germany
³Clinical Cooperation Group Immunooncology, Helmholtz Zentrum München, Munich, Germany
⁴Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany
⁵Department of Transfusion Medicine, Cellular Therapeutics and Hemostaseology, Klinikum der Universität München, Munich, Germany
⁶Department of Cellular Therapy, Oslo University Hospital, Oslo, Norway

Nandini Rudra-Ganguly, PhD¹, Christine Lowe^1*, Cyrus Virata^1*, Monica Leavitt^1*, Liqing Jin, MD^2*, Brian Mendelsohn, PhD^1*, Josh Snyder^1*, Hector Aviña^1*, Chunying Zhang^1*, Deanna L Russell^1*, Michael Mattie, PhD^1*, Peng Yang, PhD^1*, Baljinder Randhawa^1*, Gao Liu^1*, Faisal Malik^1*, Misty Vest^1*, Joseph D Abad^1*, Christopher C Kemball, PhD^1*, René Hubert, PhD^1*, Sher Karki, PhD^1*, Banmeet Anand, PhD^1*, Zili An, MD^1*, Jeanette Grant, PhD^1*, John E. Dick, PhD², Fernando Doñate, PhD^1*, Kendall Morrison, PhD^1*, Pia Challita-Eid, PhD^1*, Ingrid B Joseph, DVM, PhD^1*, Daniel S. Pereira, PhD¹ and David R. Stover, PhD^1*

¹Agensys Inc., an Affiliate of Astellas Pharma Inc., Santa Monica, CA
²Division of Cell and Molecular Biology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Yann Duchartre, PhD^1*, EunJi Gang, MD PhD^1*, Hye Na Kim^1*, Stephanie Nicole Shishido, PhD^2*, Muller Fabbri, MD^1*, Anatoly Grishin, PhD^3*, Chintan Parekh, MBBS^1*, Hisham Abdel-Azim, MD², Deepa Bhojwani, MD^1*, Alan S. Wayne, MD², George Tachas, PhD^4* and Yong-Mi Kim, MD PhD MPH²

¹Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles
²Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA
³Department of Pediatrics, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles
⁴Antisense Therapeutics Ltd, Toorak, Melbourne, Australia

Aref Al-Kali, MD¹, Raoul Tibes, MD, PhD², Jeanne Palmer, MD^3*, Hassan B Alkhateeb, MD^1*, Pamela Atherton^4*, Fei Yan^5*, Shujun Liu, PhD⁵, Rong He, MD⁶, Shahrukh K. Hashmi, M.D.^1* and Mark R Litzow, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ
³Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
⁴Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN
⁵Hormel Institute, University of Minnesota, Austin, MN
⁶Division of Hematopathology, Special Coagulation Laboratory, Mayo Clinic, Rochester, MN

Dale Bixby, MD, PhD¹, Matthew J. Wieduwilt, MD, PhD², Luke Paul Akard, MD³, H. Jean Khoury, MD⁴, Pamela S. Becker, MD, PhD⁵, Edward H. Van Der Horst, PhD⁶, William Ho, MD, PhD⁷ and Jorge E. Cortes, MD⁸

¹Univ. of Michigan Comprehensive Cancer Ctr., Ann Arbor, MI
²University of California, San Diego, La Jolla, CA
³IBMT, Indianapolis, IN
⁴Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
⁵Department of Medicine/Division of Hematology, University of Washington, Seattle, WA
⁶Igenica Biotherapeutics, Burlingame, CA
⁷Igenica, Inc., Burlingame, CA
⁸Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Tsila Zuckerman, MD^1,2*, Ruth Ben Yakar, PhD^3*, Stela Gengrinovitch, PhD^3*, Ron Hoffman, MD^1,2*, Israel Henig, MD^1*, Noa Lavi, MD^1*, Luiza Akria, MD^4*, Yishai Ofran, MD^5,6*, Olga Nudelman, MD^1*, Nuhad Haddad, MD^1*, Martin S Tallman, MD^7* and Jacob M. Rowe, MD^8,9

¹Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
²Bruce Rappaport Faculty of Medicine,Technion, Haifa, Israel
³BioSight Ltd., Karmiel, Israel
⁴Department of Hematology, Western Galilee Medical Center, Nahariya, Israel
⁵The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
⁶Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
⁷Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
⁸Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel
⁹Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel